A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Clinical trial NCT05660850 · COMPLETED

Trial details

NCT number: NCT05660850
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Refractory Cough (CRC) With Non-atopic Asthma CRC With Atopic Asthma Unexplained Chronic Cough CRC With Chronic Obstructive Pulmonary Disease CRC With Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

Start date: 2023-03-22
Primary completion: 2024-10-20
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.